{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:59:12Z","timestamp":1784696352497,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Female Pelvic Med Reconstr Surg"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the effect of vaginal intraoperative infiltration of liposomal bupivacaine on vaginal pain among patients undergoing posterior colporrhaphy and perineorrhaphy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a randomized, placebo-controlled trial offered to women undergoing posterior colporrhaphy and perineorrhaphy with concomitant pelvic reconstructive procedures. Liposomal bupivacaine or normal saline placebo (30 mL) was injected into the posterior vaginal compartment and perineal body in 2- to 3-mL increments, using a systematic technique. All participants received 10-mL 0.25% bupivacaine with epinephrine prior to incision. Perioperative care was standardized. The primary outcome was vaginal pain as measured by a visual analog scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One hundred twenty-six women were screened, and 72 were included. Demographic characteristics were similar. Median visual analog scale was not different at any time point (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.81). There were no differences in secondary outcomes, including narcotic use (37.5 vs 37.5 mg morphine equivalents,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.51; placebo vs liposomal bupivacaine), time to first opioid (68 vs 89.5 minutes,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.56), antiemetic doses (3 vs 2,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.07), hospital length of stay (24 vs 21.9 hours,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.98), length of stay in postanesthesia care unit (93 vs 100 minutes,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.32), proportion of patients who had a bowel movement within the first 3 postoperative days (65.7 vs 59.5%\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.36), or successful voiding trials (45.7 vs 59.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.24). There were no differences in patient satisfaction or postoperative adverse events.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study of pelvic reconstructive surgeries with posterior colporrhaphy and perineorrhaphy, there were no differences in pain scores or any secondary outcomes between liposomal bupivacaine and placebo injected into the posterior vaginal compartment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/spv.0000000000000855","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T16:48:11Z","timestamp":1588956491000},"page":"344-350","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["A Novel Injection Technique for Extended-Release Local Anesthetic After Posterior Colporrhaphy and Perineorrhaphy: A Randomized Controlled Study"],"prefix":"10.1097","volume":"27","author":[{"given":"Sarah Keenan Larkin","family":"Evans","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Atrium Health, Charlotte"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obafunbi","family":"Abimbola","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina, Chapel Hill, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erinn M.","family":"Myers","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Atrium Health, Charlotte"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Tarr","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Atrium Health, Charlotte"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"bib2-20260610","first-page":"257","article-title":"Liposomal bupivacaine: a review of a new bupivacaine formulation","volume":"5","year":"2012","journal-title":"J Pain Res"},{"issue":"l9","key":"bib3-20260610","first-page":"19S","article-title":"Liposomal bupivacaine: an innovative nonopioid local analgesic for the management of postsurgical pain","volume":"32","year":"2012","journal-title":"Pharmacotherapy"},{"key":"bib4-20260610","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-011-0052-y","article-title":"A phase 3, randomized, placebo-controlled trial of DepoFoam\u00ae bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy","volume":"28","year":"2011","journal-title":"Adv Ther"},{"key":"bib5-20260610","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1097\/DCR.0b013e318232d4c1","article-title":"Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo- controlled trial","volume":"54","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"bib6-20260610","first-page":"CD011476","article-title":"Liposomal bupivacaine peripheral nerve block for the management of postoperative pain (review)","volume":"8","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bib7-20260610","first-page":"CD011419","article-title":"Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain","volume":"2","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"bib8-20260610","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1600-0412.2011.01234.x","article-title":"Local infiltration analgesia in urogenital prolapse surgery: a prospective, randomized, double-blind, placebo-controlled study","volume":"90","year":"2011","journal-title":"Acta Obstet Gynecol Scand"},{"key":"bib10-20260610","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/AOG.0000000000002818","article-title":"Perioperative pathways: enhanced recovery after surgery. ACOG Committee Opinion No. 750. The American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"bib11-20260610","doi-asserted-by":"crossref","first-page":"500.e1","DOI":"10.1016\/j.ajog.2018.09.029","article-title":"Liposomal bupivacaine efficacy for postoperative pain following posterior vaginal surgery: a randomized, double-blind, placebo-controlled trial","volume":"219","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"bib12-20260610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/AOG.0000000000002375","article-title":"Liposomal bupivacaine during robotic colpopexy and posterior repair: a randomized controlled trial","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"bib13-20260610","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/000313481207800540","article-title":"A double-blind, randomized, active-controlled study for post-hemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation","volume":"78","year":"2012","journal-title":"Am Surg"},{"issue":"5","key":"bib14-20260610","doi-asserted-by":"crossref","first-page":"598.e1","DOI":"10.1016\/j.ajog.2017.07.001","article-title":"Liposomal bupivacaine decreases pain following retropubic sling placement: a randomized placebo-controlled trial","volume":"217","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"bib17-20260610","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1197\/S1069-6563(03)00372-5","article-title":"Clinically important change in the visual analog scale after adequate pain control","volume":"10","year":"2003","journal-title":"Acad Emerg Med"},{"issue":"7","key":"bib18-20260610","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1526-5900(03)00716-8","article-title":"Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain","volume":"4","year":"2003","journal-title":"J Pain"},{"key":"bib19-20260610","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajog.2004.04.047","article-title":"The use of visual analog scale in urogynecologic research: a psychometric evaluation","volume":"191","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"bib21-20260610","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jamcollsurg.2013.07.385","article-title":"Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons","volume":"217","year":"2013","journal-title":"J Am Coll Surg"},{"issue":"5","key":"bib22-20260610","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jamcollsurg.2016.12.057","article-title":"An examination of American College of Surgeons NSQIP surgical risk calculator accuracy","volume":"224","year":"2017","journal-title":"J Am Coll Surg"},{"key":"bib23-20260610","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/SPV.0000000000000686","article-title":"Predictive factors of postdischarge narcotic use after female pelvic reconstructive surgery","volume":"25","year":"2019","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"bib24-20260610","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SPV.0000000000000657","article-title":"Evaluation of opioid prescriptions after urogynecologic surgery within a large health care organization: how much are we prescribing?","volume":"25","year":"2019","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"5","key":"bib25-20260610","doi-asserted-by":"crossref","first-page":"511.e1","DOI":"10.1016\/j.ajog.2019.06.002","article-title":"Multimodal opioid-sparing postoperative pain regimen compared with the standard postoperative pain regimen in vaginal pelvic reconstructive surgery: a multicenter randomized controlled trial","volume":"221","year":"2019","journal-title":"Am J Obstet Gynecol"}],"container-title":["Female Pelvic Medicine &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SPV.0000000000000855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:00:48Z","timestamp":1781110848000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SPV.0000000000000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/spv.0000000000000855","relation":{},"ISSN":["2151-8378","2154-4212"],"issn-type":[{"value":"2151-8378","type":"print"},{"value":"2154-4212","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]}}}